Suppr超能文献

轻度高苯丙氨酸血症中的认知和行为障碍。

Cognitive and behavioral impairment in mild hyperphenylalaninemia.

作者信息

Evinç S Gülin, Pektaş Emine, Foto-Özdemir Dilşad, Yıldız Yılmaz, Karaboncuk Yamaç, Bilginer-Gürbüz Berrak, Dursun Ali, Tokatlı Ayşegül, Coskun Turgay, Öktem Ferhunde, Sivri H Serap

机构信息

Departments of Child and Adolescent Psychiatry Hacettepe University Faculty of Medicine, Ankara, Turkey.

Departments of Pediatric Metabolism, Hacettepe University Faculty of Medicine, Ankara, Turkey.

出版信息

Turk J Pediatr. 2018;60(6):617-624. doi: 10.24953/turkjped.2018.06.001.

Abstract

Evinç SG, Pektaş E, Foto-Özdemir D, Yıldız Y, Karaboncuk Y, Bilginer-Gürbüz B, Dursun A, Tokatlı A, Coskun T, Öktem F, Sivri HS. Cognitive and behavioral impairment in mild hyperphenylalaninemia. Turk J Pediatr 2018; 60: 617-624. As elevated phenylalanine (Phe) is detrimental to brain functions, determining a safe upper limit of blood Phe is important for initiation of treatment plans and setting Phe targets in hyperphenlalaninemic patients. It is accepted that Phe levels below 360 μmol/L does not impair brain function and hence does not require treatment. Therefore, we aimed to compare cognitive functions and attention-related problems among healthy children and untreated patients with hyperphenylalaninemia (HPA). This study included 41 hyperphenylalaninemic patients (all HPA group) aged 6-16 years with untreated blood Phe between 240 and 600 μmol/L and 29 healthy controls. All HPA group was further divided into 2 subgroups according to their lifetime median blood Phe levels as Phe 360-600 μmol/L and Phe 240-360 μmol/L groups. Wechsler Intelligence Scale for Children-IV (WISC-IV), ConnersContinuous Performance Test (CPT), Strength and Difficulties Questionnaire (SDQ) and Schedule for Affective Disorders and Schizophrenia for School-Age Children: Present and Lifetime Version (K-SADS-PL) were performed as a comprehensive neurocognitive, attention and behavioral assessment. The study illustrated thatall HPApatients had significantly lower scores on all WISC-IV indexes compared to controls, except for Working Memory. BothPhe 360-600 μmol/LandPhe 240-360 μmol/Lsubgroups had lower Full Scale intelligence quotient (IQ) and Verbal Comprehension scores compared to controls.All HPApatients also had longer reaction times and more peer problems than controls, indicating attention deficits and behavioral problems. Since the results demonstrated that children with untreated Phe levels between 240-360 μmol/L are at higher risk for cognitive and attention-related problems, lowering thesafe` upper Phe level should be considered.

摘要

埃文奇·S·G、佩克塔什·E、福托-厄兹德米尔·D、于尔迪兹·Y、卡拉邦库克·Y、比尔吉纳-居尔布兹·B、杜尔孙·A、托卡特利·A、科斯昆·T、厄克泰姆·F、西夫里·H·S。轻度高苯丙氨酸血症患者的认知和行为障碍。《土耳其儿科学杂志》2018年;60: 617 - 624。由于升高的苯丙氨酸(Phe)对脑功能有害,确定血苯丙氨酸的安全上限对于启动治疗计划和为高苯丙氨酸血症患者设定苯丙氨酸目标很重要。人们认为苯丙氨酸水平低于360μmol/L不会损害脑功能,因此不需要治疗。因此,我们旨在比较健康儿童和未经治疗的高苯丙氨酸血症(HPA)患者的认知功能和注意力相关问题。本研究纳入了41例6 - 16岁的高苯丙氨酸血症患者(“所有HPA组”),其未经治疗的血苯丙氨酸水平在240至600μmol/L之间,以及29名健康对照。“所有HPA组”根据其终生血苯丙氨酸中位数水平进一步分为2个亚组,即“苯丙氨酸360 - 600μmol/L组”和“苯丙氨酸240 - 360μmol/L组”。采用韦氏儿童智力量表第四版(WISC - IV)、康纳斯连续操作测验(CPT)、长处与困难问卷(SDQ)以及学龄儿童情感障碍和精神分裂症量表:目前和终生版(K - SADS - PL)进行全面的神经认知、注意力和行为评估。研究表明,与对照组相比,“所有HPA”患者在所有WISC - IV指标上的得分均显著较低,但工作记忆除外。“苯丙氨酸360 - 600μmol/L组”和“苯丙氨酸240 - 360μmol/L组”与对照组相比,全量表智商(IQ)和言语理解得分均较低。“所有HPA”患者的反应时间也比对照组更长,同伴问题更多,表明存在注意力缺陷和行为问题。由于结果表明未经治疗的苯丙氨酸水平在240 - 360μmol/L之间的儿童存在认知和注意力相关问题的风险更高,因此应考虑降低“安全”苯丙氨酸上限水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验